Purpose: To investigate the accuracy of wall shear stress (WSS) estimation using MRI. Specifically, to investigate the impact of different parameters and if MRI WSS estimates are monotonically related to actual WSS. Materials and Methods:The accuracy of WSS estimation using methods based on phase-contrast (PC) MRI velocity mapping, Fourier velocity encoding (FVE) and intravoxel velocity standard deviation mapping were studied using numerical simulations. The influence of spatial resolution, velocity encoding, wall segmentation, and voxel location were investigated over a range of WSS values.Results: WSS estimates were found to be sensitive to parameter settings in general and spatial resolution in particular. All methods underestimated WSS, except for the FVE-based method, which instead was extremely sensitive to voxel position relative to the wall. Methods using PC-based WSS estimation with wall segmentation showed to be accurate for low WSS, but were sensitive to segmentation errors. Conclusion:Even in the absence of noise and for relatively simple velocity profiles, MRI WSS estimates cannot always be assumed to be linearly or even monotonically related to actual WSS. High WSS values cannot be resolved and the estimates depend on parameter setting. Nevertheless, distinguishing areas of low and moderate WSS may be feasible.

95%-CI = 95% confidence interval, COVID-19 = coronavirus disease 2019, FLAIR = fluidattenuated inversion recovery, PCR = polymerase-chain-reaction, rCBF = relative cerebral blood flow, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, SWI = susceptibility-weighted imaging.

Background & Aims The first-line treatment for non-alcoholic fatty liver disease (NAFLD) is weight reduction. Several diets have been proposed, with various effects specifically on liver steatosis. This trial compared the effects of intermittent calorie restriction (the 5:2 diet) and a low-carb high-fat diet (LCHF) on reduction of hepatic steatosis. Methods We conducted an open-label randomised controlled trial that included 74 patients with NAFLD randomised in a 1:1:1 ratio to 12 weeks’ treatment with either a LCHF or 5:2 diet, or general lifestyle advice from a hepatologist (standard of care; SoC). The primary outcome was reduction of hepatic steatosis as measured by magnetic resonance spectroscopy. Secondary outcomes included transient elastography, insulin resistance, blood lipids, and anthropometrics. Results The LCHF and 5:2 diets were both superior to SoC treatment in reducing steatosis (absolute reduction: LCHF: −7.2% [95% CI = −9.3 to −5.1], 5:2: −6.1% [95% CI = −8.1 to −4.2], SoC: −3.6% [95% CI = −5.8 to −1.5]) and body weight (LCHF: −7.3 kg [95% CI = −9.6 to −5.0]; 5:2: −7.4 kg [95% CI = −8.7 to −6.0]; SoC: −2.5 kg [95% CI =−3.5 to −1.5]. There was no difference between 5:2 and LCHF ( p = 0.41 for steatosis and 0.78 for weight). Liver stiffness improved in the 5:2 and SoC but not in the LCHF group. The 5:2 diet was associated with reduced LDL levels and was tolerated to a higher degree than LCHF. Conclusions The LCHF and 5:2 diets were more effective in reducing steatosis and body weight in patients with NAFLD than SoC, suggesting dietary advice can be tailored to meet individual preferences. Lay summary For a person with obesity who suffers from fatty liver, weight loss through diet can be an effective treatment to improve the condition of the liver. Many popular diets that are recommended for weight reduction, such as high-fat diets and diets based on intermittent fasting, have not had their effects on the liver directly evaluated. This study shows that both a low-carb high-fat and the 5:2 diet are effective in treating fatty liver caused by obesity. Clinical Trials Registration This study is registered at Clinicaltrials.gov ( NCT03118310 ).

Time-resolved three-dimensional phase contrast MRI is an important tool for physiological as well as clinical studies of flow in the heart and vessels. The application of the technique is, however, limited by the long scan times required.In the present work, we investigate the feasibility of using spiral readouts to reduce the scan time of 4D flow MRI without sacrificing quality. Three spiral approaches are presented and evaluated in-vivo and in-vitro against a conventional Cartesian acquisition. In-vivo, the performance of each method was assessed in the thoracic aorta in ten volunteers using pathline based analysis and cardiac output analysis. SNR and background phase errors were investigated invitro.Using spiral readouts, the scan times of a 4D flow acquisition of the thoracic aorta could be reduced two to threefold, with no statistically significant difference in pathline validity or cardiac output. The shortened scan time improves the applicability of 4D flow MRI, which may allow the technique to become a part of a clinical workflow for cardiovascular functional imaging.